106 related articles for article (PubMed ID: 12943693)
1. Estrogen-responsive RING finger protein controls breast cancer growth.
Horie K; Urano T; Ikeda K; Inoue S
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):101-4. PubMed ID: 12943693
[TBL] [Abstract][Full Text] [Related]
2. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.
Urano T; Saito T; Tsukui T; Fujita M; Hosoi T; Muramatsu M; Ouchi Y; Inoue S
Nature; 2002 Jun; 417(6891):871-5. PubMed ID: 12075357
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
[TBL] [Abstract][Full Text] [Related]
4. Analysis of estrogen-responsive finger protein expression in benign and malignant human breast.
Thomson SD; Ali S; Pickles L; Taylor J; Pace PE; Lymboura M; Shousha S; Coombes RC
Int J Cancer; 2001 Jan; 91(2):152-8. PubMed ID: 11146438
[TBL] [Abstract][Full Text] [Related]
5. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning of rat efp: expression and regulation in primary osteoblasts.
Inoue S; Urano T; Ogawa S; Saito T; Orimo A; Hosoi T; Ouchi Y; Muramatsu M
Biochem Biophys Res Commun; 1999 Aug; 261(2):412-8. PubMed ID: 10425199
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells.
Zhao KW; Sikriwal D; Dong X; Guo P; Sun X; Dong JT
Biochem J; 2011 Jul; 437(2):323-33. PubMed ID: 21542805
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, structure, and expression of mouse estrogen-responsive finger protein Efp. Co-localization with estrogen receptor mRNA in target organs.
Orimo A; Inoue S; Ikeda K; Noji S; Muramatsu M
J Biol Chem; 1995 Oct; 270(41):24406-13. PubMed ID: 7592654
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP.
Dong XY; Fu X; Fan S; Guo P; Su D; Dong JT
Biochem J; 2012 Jun; 444(3):581-90. PubMed ID: 22452784
[TBL] [Abstract][Full Text] [Related]
10. Efp as a primary estrogen-responsive gene in human breast cancer.
Ikeda K; Orimo A; Higashi Y; Muramatsu M; Inoue S
FEBS Lett; 2000 Apr; 472(1):9-13. PubMed ID: 10781795
[TBL] [Abstract][Full Text] [Related]
11. Chromosome mapping of human (ZNF147) and mouse genes for estrogen-responsive finger protein (efp), a member of the RING finger family.
Inoue S; Orimo A; Matsuda Y; Inazawa J; Emi M; Nakamura Y; Hori T; Muramatsu M
Genomics; 1995 Jan; 25(2):581-3. PubMed ID: 7789997
[TBL] [Abstract][Full Text] [Related]
12. Promoter analysis of mouse estrogen-responsive finger protein (efp) gene: mouse efp promoter contains an E-box that is also conserved in human.
Ikeda K; Inoue S; Orimo A; Tsutsumi K; Muramatsu M
Gene; 1998 Aug; 216(1):155-62. PubMed ID: 9714786
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic analysis of hormone-sensitive patient-derived endometrial cancer spheroid culture defines Efp as a proliferation modulator.
Yang C; Ikeda K; Horie-Inoue K; Sato W; Hasegawa K; Takeda S; Itakura A; Inoue S
Biochem Biophys Res Commun; 2021 Apr; 548():204-210. PubMed ID: 33647797
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells.
Dai H; Zhang P; Zhao S; Zhang J; Wang B
Oncol Rep; 2009 Feb; 21(2):395-401. PubMed ID: 19148513
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth.
Ueyama K; Ikeda K; Sato W; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
Cancer Gene Ther; 2010 Sep; 17(9):624-32. PubMed ID: 20467453
[TBL] [Abstract][Full Text] [Related]
16. Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein.
Inoue S; Orimo A; Hosoi T; Kondo S; Toyoshima H; Kondo T; Ikegami A; Ouchi Y; Orimo H; Muramatsu M
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11117-21. PubMed ID: 8248217
[TBL] [Abstract][Full Text] [Related]
17. Efp/TRIM25 and Its Related Protein, TRIM47, in Hormone-Dependent Cancers.
Azuma K; Inoue S
Cells; 2022 Aug; 11(15):. PubMed ID: 35954308
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancer.
Massarweh S; Osborne CK; Jiang S; Wakeling AE; Rimawi M; Mohsin SK; Hilsenbeck S; Schiff R
Cancer Res; 2006 Aug; 66(16):8266-73. PubMed ID: 16912207
[TBL] [Abstract][Full Text] [Related]
19. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase.
Zou W; Zhang DE
J Biol Chem; 2006 Feb; 281(7):3989-94. PubMed ID: 16352599
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-responsive RING finger mRNA induction in gastrointestinal carcinoma cells following bile acid treatment.
Jung B; Vogt T; Mathieu-Daudé F; Welsh J; McClelland M; Trenkle T; Weitzel C; Kullmann F
Carcinogenesis; 1998 Nov; 19(11):1901-6. PubMed ID: 9855000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]